NASDAQ:CDMO - Avid Bioservices Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.26 -0.04 (-0.93 %)
(As of 01/15/2019 04:00 PM ET)
Previous Close$4.30
Today's Range$4.17 - $4.40
52-Week Range$2.24 - $8.44
Volume319,419 shs
Average Volume252,157 shs
Market Capitalization$257.91 million
P/E Ratio-8.52
Dividend YieldN/A
Beta2.58
Avid Bioservices, Inc., a biologics contract development and manufacturing company, focuses on the development and current Good Manufacturing Practices (cGMP) manufacture of biopharmaceutical products derived from mammalian cell culture. It provides a range of process development, cGMP clinical, and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The company produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and offers services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission, and support. It also provides various process development services, such as cell line development and optimization, cell culture and feed optimization, analytical methods development, and product characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

Receive CDMO News and Ratings via Email

Sign-up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CDMO
CUSIPN/A
Phone714-508-6100

Debt

Current Ratio2.26
Quick Ratio1.84

Price-To-Earnings

Sales & Book Value

Annual Sales$53.62 million
Price / Sales4.45
Price / Cash FlowN/A
Book Value$1.00 per share
Price / Book4.26

Profitability

Net Income$-21,810,000.00
Net Margins-31.20%
Return on Assets-23.25%

Miscellaneous

Employees186
Market Cap$257.91 million
OptionableOptionable

Avid Bioservices (NASDAQ:CDMO) Frequently Asked Questions

What is Avid Bioservices' stock symbol?

Avid Bioservices trades on the NASDAQ under the ticker symbol "CDMO."

How often does Avid Bioservices pay dividends? What is the dividend yield for Avid Bioservices?

Avid Bioservices announced a dividend on Wednesday, March 7th. Shareholders of record on Monday, March 19th will be given a dividend of $0.6563 per share on Monday, April 2nd. The ex-dividend date of this dividend is Friday, March 16th. View Avid Bioservices' Dividend History.

When did Avid Bioservices' stock split? How did Avid Bioservices' stock split work?

Avid Bioservices shares reverse split on Monday, July 10th 2017. The 1-7 reverse split was announced on Friday, July 7th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2017. An investor that had 100 shares of Avid Bioservices stock prior to the reverse split would have 14 shares after the split.

How were Avid Bioservices' earnings last quarter?

Avid Bioservices Inc (NASDAQ:CDMO) posted its earnings results on Monday, December, 10th. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.03. The biopharmaceutical company had revenue of $10.18 million for the quarter, compared to analyst estimates of $10.75 million. Avid Bioservices had a negative return on equity of 38.67% and a negative net margin of 31.20%. View Avid Bioservices' Earnings History.

When is Avid Bioservices' next earnings date?

Avid Bioservices is scheduled to release their next quarterly earnings announcement on Monday, March 11th 2019. View Earnings Estimates for Avid Bioservices.

What guidance has Avid Bioservices issued on next quarter's earnings?

Avid Bioservices updated its FY 2019 earnings guidance on Monday, December, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $51-55 million, compared to the consensus revenue estimate of $54.3 million.

What price target have analysts set for CDMO?

4 equities research analysts have issued 1-year price objectives for Avid Bioservices' stock. Their predictions range from $4.00 to $11.00. On average, they anticipate Avid Bioservices' stock price to reach $8.3333 in the next year. This suggests a possible upside of 95.6% from the stock's current price. View Analyst Price Targets for Avid Bioservices.

What is the consensus analysts' recommendation for Avid Bioservices?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avid Bioservices in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Avid Bioservices.

What are Wall Street analysts saying about Avid Bioservices stock?

Here are some recent quotes from research analysts about Avid Bioservices stock:
  • 1. According to Zacks Investment Research, "Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States. " (1/11/2019)
  • 2. HC Wainwright analysts commented, "Valuation and impediments to achieving price target. We maintain our Buy rating with a price target of $11. Our valuation is based on a discounted EBITDA model, which we believe takes into account both the established and anticipated revenue growth of Avid, which is the cornerstone of the company’s business. We assign a 23x multiple on F2023 EBIDTA discounted back at Avid’s WACC of 13%. We believe that Avid deserves a multiple premium compared to recent CDMO deals in North Avid Bioservices, Inc." (12/11/2018)

Has Avid Bioservices been receiving favorable news coverage?

News articles about CDMO stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avid Bioservices earned a media sentiment score of 1.9 on InfoTrie's scale. They also gave press coverage about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are some of Avid Bioservices' key competitors?

Who are Avid Bioservices' key executives?

Avid Bioservices' management team includes the folowing people:
  • Dr. Roger J. Lias, Pres, CEO & Director (Age 58)
  • Mr. Mark R. Ziebell, VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Daniel R. Hart, Chief Financial Officer (Age 45)
  • Ms. Tracy L. Kinjerski, VP of Bus. Operations
  • Mr. Stephen Michael Hedberg, Sr. Director of Fin. & SEC Reporting and Principal Financial & Accounting Officer (Age 43)

How do I buy shares of Avid Bioservices?

Shares of CDMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Avid Bioservices' stock price today?

One share of CDMO stock can currently be purchased for approximately $4.26.

How big of a company is Avid Bioservices?

Avid Bioservices has a market capitalization of $257.91 million and generates $53.62 million in revenue each year. The biopharmaceutical company earns $-21,810,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Avid Bioservices employs 186 workers across the globe.

What is Avid Bioservices' official website?

The official website for Avid Bioservices is http://www.avidbio.com.

How can I contact Avid Bioservices?

Avid Bioservices' mailing address is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. The biopharmaceutical company can be reached via phone at 714-508-6100 or via email at [email protected]


MarketBeat Community Rating for Avid Bioservices (NASDAQ CDMO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  238 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  444
MarketBeat's community ratings are surveys of what our community members think about Avid Bioservices and other stocks. Vote "Outperform" if you believe CDMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDMO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/15/2019 by MarketBeat.com Staff

Featured Article: Federal Reserve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel